Salutogenesis > pathogenesis? New @uthealthsa.bsky.social study in Aging Cell — TCF7-linked immune resilience may counter "pathogenic triad" of inflammaging, immune aging and senescence.

@uthealthsa.bsky.social researchers uncovered a key mechanism for preserving thymic function and immune health as we age. Led by Ann Griffith, PhD, the study, published in @nature Aging, reveals that FGF21 plays a crucial role in maintaining thymic size and enhancing T-cell differentiation.

UT Health San Antonio scientists gained new insight into the macrophage polarization process, highlighting the importance of a certain protein’s (TRPM7) action on magnesium ion channels. @uthealthsa.bsky.social

A research team led by Dr. Hong-yu Li, UT Health San Antonio, has uncovered CD36-mediated chemical endocytosis, enabling large, polar drugs to efficiently enter cells. Could reshape oral bioavailability, BBB penetration & precision medicine. @uthealthsa.bsky.social @uthealthbarshop.bsky.social

Dr. Xianlin Han spoke recently on ASBMB Breakthroughs, a monthly webinar series highlighting research from ASBMB journals. Unsheathing the role of myelin lipids in Alzheimer’s disease www.asbmb.org/asbmb-today/...

Big news! UT Health San Antonio has earned a prestigious Research 1 designation from the Carnegie Foundation, placing it among the top 4.7% of U.S. institutions. This achievement highlights UT Health San Antonio’s leadership in groundbreaking biomedical discoveries and medical education.

News! NIH launches 20 new grants to understand pathobiology of #LongCovid by analysis of data and specimens from the national NIH RECOVER cohort study. Excited for our team @uthealthsa.bsky.social, Mark Shapiro, Tom Patterson, and colleagues across 4 institutions. recovercovid.org/pathobiology

UT Health San Antonio’s Dr. Mohamad Habes is leading a $16M NIH-funded study using AI-powered imaging to better understand tau protein buildup and vascular risk in Hispanic populations. This groundbreaking research could lead to earlier detection and better interventions. #UTHealthSA

A study from UT Health San Antonio used advanced imaging to observe 3,000 neurons in real time, revealing how TMJ disorders trigger chronic pain and link to migraines. With CGRP-targeting drugs showing promise, this could be a game-changer for millions affected. #TMJ #ChronicPain #UTHealthSA

A new global study underscores the long-term impact of COVID-19 on brain health, particularly in older adults. Researchers found that long COVID can trigger cognitive issues, with older adults facing double the risk of moderate to severe dementia-like impairment. #UTHealthSA #LongCOVID #BrainHealth

Celebrating 50 Years of Excellence: UT Health San Antonio MD Anderson Cancer Center @uthealthsamda.bsky.social @mdanderson.bsky.social oncodaily.com/insight/210687 #Cancer #OncoDaily #Oncology #UTHealthSanAntonio #Health #MaysCancerCenter #MDAndersonCancerCenter #Medicine

New press release: Females have a 31% higher associated risk of developing long COVID, UT Health San Antonio-led RECOVER study shows www.eurekalert.org/news-release... ME/CFS has been found to be consistently higher in females #LongCovid #MEcfs

Nice article including some of the great benefits of the upcoming UTSA/UT Health San Antonio merger!

New research from @UTHealthSA and @UTHealthHouston at San Antonio explores how community violence impacts dental care access. Understanding this link can shape interventions, improve health equity & expand medical-dental integration. #UTHSAResearch #PublicHealth #DentalCare

Exciting news! news.uthscsa.edu/dr-monica-ve...

Scientists from @uthealthsa.bsky.social & Hirosaki Univ. used bumetanide to restore social skills in fragile X mice. Early treatment improved neonatal behavior but reduced post-pubertal socialization, suggesting distinct mechanisms for early vs. later social behaviors. #FragileX #AutismResearch

@uthealthsa.bsky.social is leading a bioinformatics program to train African scientists in neurodegenerative disease research. The AI-BOND initiative builds capacity to tackle rising dementia cases in Africa. #SanAntonioScience #AIBONDInitiative #DementiaResearch @alzassociation.bsky.social

Philip Serwer, PhD, @uthealthsa.bsky.social is advancing phage research  — using natural bacteria-eaters to fight drug-resistant infections. With new funding & novel discoveries, the city is becoming a global hub for this cutting-edge research. #PhageResearch #AntibioticResistance #FutureOfMedicine

@uthealthsa.bsky.social scientists identify certain APOE transcript that influences risk across ε2, ε3, and ε4 alleles. Diverse brain datasets highlight its consistent role across ancestries. @nature.com @natureportfolio.bsky.social   #Alzheimers #Dementia #neurodegeneraticdiseases

Discover groundbreaking work at UT Health San Antonio addressing eating disorders in older Hispanic women. This collaborative study explores critical health challenges and how community-based research is making a difference. Read the full story here:

Hot off the press! Check our our latest Future Magazine from the #UTHealthSA Long School of Medicine. This issue's all about brain health. #biomed #UTHSAReseach #science #brain #mentalhealth #BeWell magazines.uthscsa.edu/schools/futu...

An article about research conducted by teams from UT Health San Antonio and the University of Chicago is listed as one of the best Medical XPress articles for 2024. medicalxpress.com/news/2024-12...

The University of Texas Health Science Center at San Antonio proudly opens the doors to its new UT Health San Antonio Multispecialty and Research Hospital today! #UTHealthSA #UTHSAResarch #hope #clinicaltrials #biomed

A groundbreaking study by UT Health San Antonio (@uthealthsa.bsky.social) links genetic changes to social behavior differences in autism and schizophrenia. Tbx1 gene deficiency impacts brain volume and social interaction. #UTHealthSA #WeMakeLivesBetter #EverythingItTakes

During COVID-19, South Texas community health clubs went virtual to tackle vaccine hesitancy in Latino communities. A UT Health San Antonio study shows they boosted confidence, vaccination rates & shared accurate info. 🌟#UTHealthSA #UTHSAResearch #PublicHealth #CommunityCare #COVID19 #LatinoHealth

Dr. Ronald Rodriguez of UT Health San Antonio's study reveals that a combination of valproic acid and DHA could reduce the risk of contracting COVID-19 or lessen its severity.

Marzieh Salehi, MD, MS, with UT Health San Antonio, recently received NIH funding of $3 million to conduct a first-of-its-kind clinical trial investigating the causes of diabetes and obesity in people with spinal cord injuries.

UT Health San Antonio was awarded $12 million by NIH/NIDA to further develop methocinnamox as a potential opioid use disorder treatment. Charles P. France, PhD, leads the drug development program.

Learn more about how UT Health San Antonio is making a difference through telemedicine, research, and collaborative programs:

Breakthrough in pancreatic cancer research: UT Health San Antonio scientists have developed a pioneering model of pancreatic cancer that could lead to early detection and new treatments.

A groundbreaking study published this month in Nature by UT Health San Antonio and University of Chicago scientists shows for the first time how TET2 mutations contribute to certain blood cancers.

UT Health San Antonio has contributed a rare dataset to the Gabriella Miller Kids First Pediatric Research Program. This dataset focuses on chromosome 18 conditions and rare birth defects.

UT Health San Antonio and UC Berkeley scientists have developed a cutting-edge lipid nanoparticle system that delivers mRNA to the brain & beyond. This could revolutionize treatments for Alzheimer's, epilepsy and more. Learn more:

Stress-triggered migraines may soon meet their match — UT Health San Antonio scientist Yu Shin Kim, PhD, identified a pathway behind stress-induced migraines, paving the way for new treatments.

A neuroscientist at UT Health San Antonio, is uncovering the brain’s role in Duchenne muscular dystrophy, shedding light on cognitive symptoms like memory loss and autism links. He is leading multiple breakthroughs in understanding dystrophin’s impact on neurons.

Fat cells were found to retain a long-lasting "memory" of obesity making it hard to maintain weight loss results.

The vaccine is the second to be approved by the UN agency and the first approved for children aged one and older.